First, the stepwise increase in weight loss as additional receptor mechanisms are added (GLP-1 only to GLP-1+GIP to GLP-1+GIP+glucagon) is consistent with the additive-mechanism hypothesis that underpinned the retatrutide program
As with any new medicine, phase 3 trials and ongoing pharmacovigilance will define the real-world safety picture
Research your destination country's regulations, carry a detailed prescriber's letter, declare the medication at customs, and if you are a clinical trial participant, obtain explicit approval from your trial sponsor before travelling abroad
Executive Functioning Difficulties Problems with setting goals, focusing, remembering tasks, and managing work can cause upset and irritation
30:389-394 [PubMed: 17259518] 40
and (c) IcoSema, icodec, and semaglutide were all safe with no differences in AE frequency, severity, causality, or outcome